We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

39 hedge funds and large institutions have $6.51M invested in Biotech Acquisition Company Warrant in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

15% more funds holding

Funds holding: 34 → 39 (+5)

3% more capital invested

Capital invested by funds: $6.34M → $6.51M (+$166K)

Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
3
Closed
1
Calls
$1.36M
Puts
–
Net Calls
+$1.36M
Net Calls Change
+$214K

Top Buyers

Rank Fund Capital Flow
1
SRCM
Sage Rock Capital Management
New York
+$213K
2
RA
Ramius Advisors
New York
+$90.8K
3
RCM
Rivernorth Capital Management
Florida
+$83.7K
4
ACA
Arena Capital Advisors
California
+$74.4K
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$55.8K

Top Sellers

Rank Fund Capital Flow
1
KSCM
Kamunting Street Capital Management
Florida
-$137K
2
WAM
Wolverine Asset Management
Illinois
-$9.05K
3
Jane Street
Jane Street
New York
-$660
4
EAM
Exos Asset Management
New York
-$69
Name Holding Trade Value Shares
Change 		Change in
Stake
PMAM
26
Picton Mahoney Asset Management
Ontario, Canada
$51K +$55.8K +75,000 New
WAM
27
Wolverine Asset Management
Illinois
$34K -$9.05K -12,166 -19%
Jane Street
28
Jane Street
New York
$33K -$660 -887 -2%
CP
29
Centerbridge Partners
New York
$33K – – –
CCA
30
Castle Creek Arbitrage
Colorado
$32K – – –
QGA
31
Q Global Advisors
Texas
$26K +$28.9K +38,788 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$20K – – –
AA
33
AQR Arbitrage
Connecticut
$17K – – –
PCM
34
Prelude Capital Management
New York
$11K – – –
EAM
35
Exos Asset Management
New York
$8K -$69 -93 -0.7%
BCM
36
Basso Capital Management
Connecticut
$8K +$1.56K +2,096 +19%
OAC
37
OMERS Administration Corp
Ontario, Canada
$8K +$9.3K +12,500 New
Bank of America
38
Bank of America
North Carolina
$7K – – –
AA
39
Ancora Advisors
Ohio
$4K +$223 +300 +6%
KSCM
40
Kamunting Street Capital Management
Florida
– -$137K -158,962 Closed
1
2

BIOTW Hedge Fund Activity: Q3 2021 in Review

39 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q3 2021, worth a combined $6.51M — up 2.6% from $6.34M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIOTW positions and 1 closed out — a net gain of 5 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Sage Rock Capital Management, opening a new position worth an estimated $213K. The largest seller was Kamunting Street Capital Management, exiting entirely with an estimated $137K sold.

  • 39 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q3 2021, up from 34 in Q2 2021.
  • Funds reported $6.51M of Biotech Acquisition Company Warrant stock for Q3 2021, up 2.6% quarter-over-quarter.
  • 6 funds opened new Biotech Acquisition Company Warrant positions in Q3 2021 and 1 closed out, a net change of +5 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q3 2021 was Sage Rock Capital Management, an estimated $213K added.
  • The largest Biotech Acquisition Company Warrant seller in Q3 2021 was Kamunting Street Capital Management, an estimated $137K sold.

Based on aggregated 13F filings for Q3 2021.